168 related articles for article (PubMed ID: 21965431)
1. Automated quantitative drug susceptibility testing of non-tuberculous mycobacteria using MGIT 960/EpiCenter TB eXiST.
Lucke K; Hombach M; Friedel U; Ritter C; Böttger EC
J Antimicrob Chemother; 2012 Jan; 67(1):154-8. PubMed ID: 21965431
[TBL] [Abstract][Full Text] [Related]
2. Drug susceptibility distributions in slowly growing non-tuberculous mycobacteria using MGIT 960 TB eXiST.
Hombach M; Somoskövi A; Hömke R; Ritter C; Böttger EC
Int J Med Microbiol; 2013 Jul; 303(5):270-6. PubMed ID: 23689069
[TBL] [Abstract][Full Text] [Related]
3. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
[TBL] [Abstract][Full Text] [Related]
4. Differences in risk factors and drug susceptibility between Mycobacterium avium and Mycobacterium intracellulare lung diseases in China.
Zhang Z; Pang Y; Wang Y; Cohen C; Zhao Y; Liu C
Int J Antimicrob Agents; 2015 May; 45(5):491-5. PubMed ID: 25795316
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the nitrate-based colorimetric method for testing the susceptibility of Mycobacterium tuberculosis to streptomycin and ethambutol in liquid cultures.
Syre H; Valvatne H; Sandven P; Grewal HM
J Antimicrob Chemother; 2006 May; 57(5):987-91. PubMed ID: 16524896
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L
Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398
[TBL] [Abstract][Full Text] [Related]
7. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to front line antituberculosis drugs and comparison with the radiometric BACTEC 460 TB method].
Sinirtaş M; Ozakin C; Gedikoğlu S
Mikrobiyol Bul; 2009 Jul; 43(3):403-9. PubMed ID: 19795615
[TBL] [Abstract][Full Text] [Related]
9. Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008.
Wang HX; Yue J; Han M; Yang JH; Gao RL; Jing LJ; Yang SS; Zhao YL
Chin Med J (Engl); 2010 Jan; 123(2):184-7. PubMed ID: 20137367
[TBL] [Abstract][Full Text] [Related]
10. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.
Garrigó M; Aragón LM; Alcaide F; Borrell S; Cardeñosa E; Galán JJ; Gonzalez-Martín J; Martin-Casabona N; Moreno C; Salvado M; Coll P
J Clin Microbiol; 2007 Jun; 45(6):1766-70. PubMed ID: 17442793
[TBL] [Abstract][Full Text] [Related]
11.
Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
[TBL] [Abstract][Full Text] [Related]
12. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of Mycobacterium kansasii to the difluorinated quinolone sparfloxacin using a broth microdilution and macrodilution MIC system.
Royo P; Martín-Casabona N; Martínez E; Andonegui M
Int J Tuberc Lung Dis; 1999 Apr; 3(4):349-53. PubMed ID: 10206507
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the mycobacteria growth indicator tube with radiometric and solid culture for isolation of mycobacteria from clinical specimens and susceptibility testing of Mycobacterium tuberculosis.
Ardito F; Sanguinetti M; Sechi L; Posteraro B; Masucci L; Fadda G; Zanetti S
New Microbiol; 2000 Apr; 23(2):151-8. PubMed ID: 10872685
[TBL] [Abstract][Full Text] [Related]
15. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
El-Sayed Zaki M; Goda T
Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
[TBL] [Abstract][Full Text] [Related]
16. Drug susceptibility testing of nontuberculous mycobacteria.
van Ingen J; Kuijper EJ
Future Microbiol; 2014; 9(9):1095-110. PubMed ID: 25340838
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems.
Huang TS; Tu HZ; Lee SS; Huang WK; Liu YC
Ann Clin Lab Sci; 2002; 32(2):142-7. PubMed ID: 12017195
[TBL] [Abstract][Full Text] [Related]
18. Omadacycline drug susceptibility testing for non-tuberculous mycobacteria using oxyrase to overcome challenges with drug degradation.
Boorgula GD; Gumbo T; Singh S; McShane PJ; Philley JV; Srivastava S
Tuberculosis (Edinb); 2024 Jul; 147():102519. PubMed ID: 38754247
[TBL] [Abstract][Full Text] [Related]
19. Non-tuberculous mycobacteria pulmonary infection: management and follow-up of 31 infected patients.
Andréjak C; Lescure FX; Douadi Y; Laurans G; Smail A; Duhaut P; Jounieaux V; Schmit JL
J Infect; 2007 Jul; 55(1):34-40. PubMed ID: 17360040
[TBL] [Abstract][Full Text] [Related]
20. Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System.
Rodrigues C; Jani J; Shenai S; Thakkar P; Siddiqi S; Mehta A
Int J Tuberc Lung Dis; 2008 Dec; 12(12):1449-55. PubMed ID: 19017456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
